Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001773751-25-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-14 | 2025-02-12 | HIMS | Baird Melissa | COO | S - Sale+OE | $44.72 | -67.7K | 706.9K | -9% | -$3.03M |
| D | 2025-02-14 | 2025-02-12 | HIMS | Baird Melissa | COO | M - OptEx | $0.4 | +67.7K | 774.6K | +10% | +$27.1K |
| D | 2025-02-14 | 2025-02-12 | HIMS | Baird Melissa | COO | M - OptEx | $0.00 | -67.7K | 122.2K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-12 | S | D | 18,759 | $45.45 | 716,987 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.965 - $45.785. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2025-02-12 | S | D | 23,172 | $44.35 | 735,746 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $43.955 - $44.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2025-02-12 | S | D | 15,641 | $43.37 | 758,918 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $42.94 - $43.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Class A Common Stock | 2025-02-12 | M | A | 67,687 | $0.4 | 774,559 | D | — | — | |
| 5 | Common | Class A Common Stock | 2025-02-12 | S | D | 10,115 | $46.27 | 706,872 | D | — | — | (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $45.96 - $46.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (right to buy) | 2025-02-12 | M | D | 67,687 | $0.00 | 122,243 | D | $0.4 · — to 2028-03-28 | 67,687 Class A Common Stock | (F6) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. |